Candidate gene studies in gallbladder cancer: A systematic review and meta-analysis

Mutation Research - Reviews in Mutation Research

Volumn 728, Issue 1-2, 2011, Pages 67-79

  Srivastava, Kshitij ^a   Srivastava, Anvesha ^b   Sharma, Kiran Lata ^b   Mittal, Balraj ^b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer; Gallbladder cancer; Meta analysis; Polymorphism; Review

Indexed keywords

CASPASE 8; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTOCHROME P450 1A1; DNA METHYLTRANSFERASE 3B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8 RECEPTOR; K RAS PROTEIN; PROTEIN MSH2; PROTEIN P53; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ANGIOGENESIS; CYP 1A1 GENE; DNA POLYMORPHISM; DNA REPAIR; GALLBLADDER CANCER; GENE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GSTM 1 GENE; HUMAN; INFLAMMATION; METABOLISM; NONHUMAN; OGG 1 GENE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TP 53 GENE;

GALLBLADDER NEOPLASMS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 79961207743     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2011.06.002     Document Type: Review

References (111)

1. Pitt H.A., Dooley W.C., Yeo C.J., Cameron J.L. Malignancies of the biliary tree. Curr. Probl. Surg. 1995, 32:1-90.
2. Nagorney D.M., McPherson G.A. Carcinoma of the gallbladder and extrahepatic bile ducts. Semin. Oncol. 1988, 15:106-115.
3. Dhir V., Mohandas K.M. Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas. Indian J. Gastroenterol. 1999, 18:24-28.
4. Lazcano-Ponce E.C., Miquel J.F., Muñoz N., Herrero R., Ferrecio C., Wistuba I.I., Alonso de Ruiz P., Aristi Urista G., Nervi F. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J. Clin. 2001, 51:349-364.
5. Pandey M. Environmental pollutants in gallbladder carcinogenesis. J. Surg. Oncol. 2006, 93:640-643.
6. Pandey M., Shukla V.K. Diet and gallbladder cancer: a case-control study. Eur. J. Cancer Prev. 2002, 11:365-368.
7. Kapoor V.K., McMichael A.J. Gallbladder cancer: an 'Indian' disease. Natl. Med. J. India 2003, 16:209-213.
8. Srivastava A., Mittal B. Complement receptor 1(A3650G RsaI and Intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population. Scand. J. Immunol. 2009, 70:614-620.
9. Srivastava A., Pandey S.N., Choudhuri G., Mittal B. CCR5 delta32 polymorphism: associated with gallbladder cancer susceptibility. Scand. J. Immunol. 2008, 67:516-522.
10. Srivastava A., Pandey S.N., Choudhuri G., Mittal B. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. Mol. Genet. Metab. 2008, 94:83-89.
11. Srivastava A., Pandey S.N., Dixit M., Choudhuri G., Mittal B. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer. J. Gastroenterol. Hepatol. 2008, 23:970-975.
12. Srivastava A., Pandey S.N., Pandey P., Choudhuri G., Mittal B. No association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer. DNA Cell Biol. 2008, 27:127-132.
13. Srivastava A., Srivastava K., Pandey S., Choudhuri G., Mittal B. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in north Indian population. Ann. Surg. Oncol. 2009, 16:1695-1703.
14. Srivastava A., Tulsyan S., Pandey S.N., Choudhuri G., Mittal B. Single nucleotide polymorphism in the ABCG8 transporter gene is associated with gallbladder cancer susceptibility. Liver Int. 2009, 29:831-837.
15. Srivastava K., Srivastava A., Mittal B. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of northern India. Cancer 2010, 116:3160-3169.
16. Srivastava K., Srivastava A., Pandey S., Kumar A., Mittal B. Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population. J. Gastroenterol. 2009, 44:774-780.
17. Park S.K., Andreotti G., Sakoda L.C., Gao Y.T., Rashid A., Chen J., Chen B.E., Rosenberg P.S., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Yeager M., Chanock S., Hsing A.W. Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China. Carcinogenesis 2009, 30:606-614.
18. Hsing A.W., Gao Y.T., Han T.Q., Rashid A., Sakoda L.C., Wang B.S., Shen M.C., Zhang B.H., Niwa S., Chen J., Fraumeni J..F. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br. J. Cancer 2007, 97:1577-1582.
19. Hsing A.W., Sakoda L.C., Rashid A., Andreotti G., Chen J., Wang B.S., Shen M.C., Chen B.E., Rosenberg P.S., Zhang M., Niwa S., Chu L., Welch R., Yeager M., Fraumeni J..F., Gao Y.T., Chanock S.J. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res. 2008, 68:6442-6452.
20. Pandey S.N., Choudhuri G., Mittal B. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population. Eur. J. Cancer Prev. 2008, 17:77-81.
21. Pandey S.N., Dixit M., Choudhuri G., Mittal B. Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility. Int. J. Gastrointest. Cancer 2006, 37:124-128.
22. Pandey S.N., Jain M., Nigam P., Choudhuri G., Mittal B. Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in north India. Biomarkers 2006, 11:250-261.
23. Pandey S.N., Modi D.R., Choudhuri G., Mittall B. Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease. Cancer Biol. Ther. 2007, 6:91-96.
24. Pandey S.N., Srivastava A., Dixit M., Choudhuri G., Mittal B. Haplotype analysis of signal peptide (insertion/deletion) and XbaI polymorphisms of the APOB gene in gallbladder cancer. Liver Int. 2007, 27:1008-1015.
25. Vishnoi M., Pandey S.N., Choudhuri G., Mittal B. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population. Cancer Genet. Cytogenet. 2008, 186:63-68.
26. Vishnoi M., Pandey S.N., Choudhury G., Kumar A., Modi D.R., Mittal B. Do TNFA-308 G/A and IL6-174 G/C gene polymorphisms modulate risk of gallbladder cancer in the north Indian population?. Asian Pac. J. Cancer Prev. 2007, 8:567-572.
27. Vishnoi M., Pandey S.N., Modi D.R., Kumar A., Mittal B. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1-509C>T gene polymorphisms with gallbladder cancer. Hum. Immunol. 2008, 69:360-367.
28. Abbate A., Scarpa S., Santini D., Palleiro J., Vasaturo F., Miller J., Morales C., Vetrovec G.W., Baldi A. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int. J. Cardiol. 2006, 111:371-376.
29. Isomura Y., Yamaji Y., Ohta M., Seto M., Asaoka Y., Tanaka Y., Sasaki T., Nakai Y., Sasahira N., Isayama H., Tada M., Yoshida H., Kawabe T., Omata M., Koike K. A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer. J. Gastroenterol. 2010, 45:1045-1052.
30. Chanock S.J., Manolio T., Boehnke M., Boerwinkle E., Hunter D.J., Thomas G., Hirschhorn J.N., Abecasis G., Altshuler D., Bailey-Wilson J.E., Brooks L.D., Cardon L.R., Daly M., Donnelly P., Fraumeni J..F., Freimer N.B., Gerhard D.S., Gunter C., Guttmacher A.E., Guyer M.S., Harris E.L., Hoh J., Hoover R., Kong C.A., Merikangas K.R., Morton C.C., Palmer L.J., Phimister E.G., Rice J.P., Roberts J., Rotimi C., Tucker M.A., Vogan K.J., Wacholder S., Wijsman E.M., Winn D.M., Collins F.S. Replicating genotype-phenotype associations. Nature 2007, 447:655-660.
31. Ioannidis J.P., Lau J. Pooling research results: benefits and limitations of meta-analysis. Jt. Comm. J. Qual. Improv. 1999, 25:462-469.
32. Cohn L.D., Becker B.J. How meta-analysis increases statistical power. Psychol. Methods 2003, 8:243-253.
33. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315:1533-1537.
34. Hunter J.E., Schmidt F.L. Methods of Metaanalysis: Correcting Error and Bias in Research Findings 1990, Sage, Newbury Park, CA.
35. Anonymous Freely associating. Nat. Genet. 1999, 22:1-2.
36. Bogardus S.T.J., Concato J., Feinstein A.R. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA 1999, 281:1919-1926.
37. Romero R., Kuivaniemi H., Tromp G., Olson J. The design, execution, and interpretation of genetic association studies to decipher complex diseases. Am. J. Obstet. Gynecol. 2002, 187:1299-1312.
38. Cooper D.N, Nussbaum R.L., Krawczak M. Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum. Genet. 2002, 110:207-208.
39. Clark M., Baudouin S. A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med. 2006, 32:1706-1712.
40. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 2004, 96:434-442.
41. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 1955, 19:251-253.
42. Thakkinstian A., McElduff P., D'Este C., Duffy D., Attia J. A method for meta-analysis of molecular association studies. Stat. Med. 2005, 24:1291-1306.
43. Trikalinos T.A., Salanti G., Khoury M.J., Ioannidis J.P. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am. J. Epidemiol. 2006, 163:300-309.
44. Ioannidis J.P., Boffetta P., Little J., O'Brien T.R., Uitterlinden A.G., Vineis P., Balding D.J., Chokkalingam A., Dolan S.M., Flanders W.D., Higgins J.P., McCarthy M.I., McDermott D.H., Page G.P., Rebbeck T.R., Seminara D., Khoury M.J. Assessment of cumulative evidence on genetic associations: interim guidelines. Int. J. Epidemiol. 2008, 37:120-132.
45. Tsuchiya Y., Sato T., Kiyohara C., Yoshida K., Ogoshi K., Nakamura K., Yamamoto M. Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer. J. Exp. Clin. Cancer Res. 2002, 21:119-124.
46. Singh M.K., Pandey U.B., Ghoshal U.C., Srivenu I., Kapoor V.K., Choudhuri G., Mittal B. Apolipoprotein B-100 XbaI gene polymorphism in gallbladder cancer. Hum. Genet. 2004, 114:280-283.
47. Tsuchiya Y., Baez S., Calvo A., Pruyas M., Nakamura K., Kiyohara C., Oyama M., Ikegami K., Yamamoto M. Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women. Int. J. Biol. Markers 2010, 25:75-78.
48. Srivastava K., Srivastava A., Mittal B. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. Cancer 2010, 116:3160-3169.
49. Huang W.Y, Gao Y.T., Rashid A., Sakoda L.C., Deng J., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Chen B.E., Rosenberg P.S., Chanock S.J., Hsing A.W. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis 2008, 29:100-105.
50. Jiao X., Huang J., Wu S., Lv M., Hu Y., Jianfu X., Su C., Luo B., Ce hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int. J. Cancer 2007, 121:501-505.
51. Kimura A., Tsuchiya Y., Lang I., Zoltan S., Nakadaira H., Ajioka Y., Kiyohara C., Oyama M., Nakamura K. Effect of genetic predisposition on the risk of gallbladder cancer in Hungary. Asian Pac. J. Cancer Prev. 2008, 9:391-396.
52. Tsuchiya Y., Kiyohara C., Sato T., Nakamura K., Kimura A., Yamamoto M. Polymorphisms of cytochrome P450 1A1, glutathione S-transferase class mu, and tumour protein p53 genes and the risk of developing gallbladder cancer in Japanese. Clin. Biochem. 2007, 40:881-886.
53. Jiao X., Ren J., Chen H., Ma J., Rao S., Huang K., Wu S., Fu J., Su X., Luo C., Shi J., Broelsch C.E. Ala499Val (C>T) and Lys939Gln (A>C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma: a case-control study in China. Carcinogenesis 2011, 32:496-501.
54. Park S.K., Andreotti G., Rashid A., Chen J., Rosenberg P.S., Yu K., Olsen J., Gao Y.T., Deng J., Sakoda L.C., Zhang M., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Yeager M., Chanock S.J., Hsing A.W. Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Carcinogenesis 2010, 31:842-846.
55. Srivastava A., Choudhuri G., Mittal B. CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population. Metabolism 2010, 59:767-773.
56. Pramanik V., Sarkar B.N., Kar M., Das G., Malay B.K., Sufia K.K., Lakkakula B.V., Vadlamudi R.R. A novel polymorphism in codon 25 of the KRAS gene associated with gallbladder carcinoma patients of the eastern part of India. Genet. Test Mol. Biomark. 2011.
57. Srivastava K., Srivastava A., Kumar A., Mittal B. Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Liver Int. 2010, 30:1067-1072.
58. Srivastava K., Srivastava A., Mittal B. Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population. Mol. Carcinog. 2010, 49:684-692.
59. Srivastava K., Srivastava A., Mittal B. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J. Hum. Genet. 2010, 55:495-499.
60. Srivastava K., Srivastava A., Mittal B. DNMT3B -579 G>T promoter polymorphism and risk of gallbladder carcinoma in North Indian population. J. Gastrointest. Cancer 2010, 41:248-253.
61. Srivastava K., Srivastava A., Mittal B. Angiotensin I-converting enzyme insertion/deletion polymorphism and increased risk of gall bladder cancer in women. DNA Cell Biol. 2010, 29:417-422.
62. Srivastava K., Srivastava A., Kumar A., Mittal B. Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes. PLoS One 2011, 6:e16449.
63. Baez S., Tsuchiya Y., Calvo A., Pruyas M., Nakamura K., Kiyohara C., Oyama M., Yamamoto M. Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women. World J. Gastroenterol. 2010, 16:372-378.
64. Xu H.L., Cheng J.R., Andreotti G., Gao Y.T., Rashid A., Wang B.S., Shen M.C., Chu L.W., Yu K., Hsing A.W. Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Carcinogenesis 2011, 32:58-62.
65. Andreotti G., Chen J., Gao Y.T., Rashid A., Chen B.E., Rosenberg P., Sakoda L.C., Deng J., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Yeager M., Welch R., Chanock S., Fraumeni J..F., Hsing A.W. Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Cancer Epidemiol. Biomark. Prev. 2008, 17:525-534.
66. Wistuba, Gazdar A.F. Gallbladder cancer: lessons from a rare tumour. Nat. Rev. Cancer 2004, 4:695-706.
67. Bartsch H., Nair J. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect. Prev. 2004, 28:385-391.
68. Jackson H.H., Glasgow R.E., Mulvihill S.J., Cannon-Albright L.A. Familial risk in gallbladder cancer. J. Am. Coll. Surg. 2007, 205:S38-S138.
69. Hemminki K., Li X. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut 2003, 52:592-596.
70. Blomeke B., Shields P.G. Laboratory Methods for the Determination of Genetic Polymorphisms in Humans 1999, IARC Sci Publ, pp. 133-147.
71. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006, 295:676-680.
72. Yagyu K., Kikuchi S., Obata Y., Lin Y., Ishibashi T., Kurosawa M., Inaba Y., Tamakoshi A. Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan. Int. J. Cancer 2008, 122:924-929.
73. Shukla V.K, Chauhan V.S., Mishra R.N., Basu S. Lifestyle, reproductive factors and risk of gallbladder cancer. Singapore Med. J. 2008, 49:912-915.
74. Srivastava A., Srivastava K., Pandey S.N., Choudhuri G., Mittal B. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population. Ann. Surg. Oncol. 2009, 16:1695-1703.
75. Shukla V.K., Khandelwal C., Roy S.K., Vaidya M.P. Primary carcinoma of the gall bladder: a review of a 16-year period at the University Hospital. J. Surg. Oncol. 1985, 28:32-35.
76. Piehler J.M., Crichlow R.W. Primary carcinoma of the gallbladder. Surg. Gynecol. Obstet. 1978, 147:929-942.
77. Hou L., Xu J., Gao Y.T., Rashid A., Zheng S.L., Sakoda L.C., Shen M.C., Wang B.S., Deng J., Han T.Q., Zhang B.H., Meyers D.A., Fraumeni J..F., Hsing A.W. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Int. J. Cancer 2006, 118:2847-2853.
78. Hsing A.W., Rashid A., Devesa S.S., Fraumeni J.F.J. Biliary tract cancer. Cancer Epidemiology and Prevention 2006, 794-805. Oxford University Press, New York. 3rd ed. D. Schottenfeld, J..F. Fraumeni (Eds.).
79. Pasquali R., Vicennati V., Gambineri A. Adrenal and gonadal function in obesity. J. Endocrinol. Invest. 2002, 25:893-898.
80. Rosenthal R. Writing meta-analytic reviews. Psychol. Bull. 1995, 118:183-192.
81. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Hillsdale, NJ.
82. Zhang M., Huang W.Y., Andreotti G., Gao Y.T., Rashid A., Chen J., Sakoda L.C., Shen M.C., Wang B.S., Chanock S., Hsing A.W. Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in china. Cancer Epidemiol. Biomark. Prev. 2008, 17:2123-2127.
83. Meyer T.E., O'Brien T.G., Andreotti G., Yu K., Li Q., Gao Y.T., Rashid A., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Niwa S., Fraumeni J..F., Hsing A.W. Androgen receptor CAG repeat length and risk of biliary tract cancer and stones. Cancer Epidemiol. Biomark. Prev. 2010, 19:787-793.
84. Chang S.C., Rashid A., Gao Y.T., Andreotti G., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Sakoda L.C., Leitzmann M.F., Chen B.E., Rosenberg P.S., Chen J., Chanock S.J., Hsing A.W. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 2008, 29:944-948.
85. Sakoda L.C., Gao Y.T., Chen B.E., Chen J., Rosenberg P.S., Rashid A., Deng J., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Cohen-Webb H., Yeager M., Welch R., Chanock S., Fraumeni J..F., Hsing A.W. Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 2006, 27:1251-1256.
86. Lazcano-Ponce E.C., Miquel J.F., Munoz N., Herrero R., Ferrecio C., Wistuba I.I., Alonso de Ruiz P., Aristi Urista G., Nervi F. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J. Clin. 2001, 51:349-364.
87. Lichtenstein P., Holm N.V., Verkasalo P.K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 2000, 343:78-85.
88. Yen S., Hsieh C.C., MacMahon B. Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral-contraceptive use. Cancer 1987, 59:2112-2116.
89. Zatonski W.A., La Vecchia C., Przewozniak K., Maisonneuve P., Lowenfels A.B., Boyle P. Risk factors for gallbladder cancer: a Polish case-control study. Int. J. Cancer 1992, 51:707-711.
90. Diehl A.K. Epidemiology of gallbladder cancer: a synthesis of recent data. J. Natl. Cancer Inst. 1980, 65:1209-1214.
91. Kimura W., Miyata R., Takahashi T., Yamashiro M. Simultaneous development of gallbladder and bile duct carcinomas with atypical epithelium intervention: a case report. Jpn. J. Clin. Oncol. 1989, 19:287-293.
92. Zatonski W.A., Lowenfels A.B., Boyle P., Maisonneuve P., Bueno de Mesquita H.B., Ghadirian P., Jain M., Przewozniak K., Baghurst P., Moerman C.J., Simard A., Howe G.R., McMichael A.J., Hsieh C.C., Walker A.M. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J. Natl. Cancer Inst. 1997, 89:1132-1138.
93. Misra N.C., Misra S., Chaturvedi A. Epidemiology, etiology and new persepective in carcinoma gallbladder. Indian J. Surg. 1998, 60:167-175.
94. Stephen A.E, Berger D.L. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery 2001, 129:699-703.
95. Leong R.W., Sung J.J. Review article: Helicobacter species and hepatobiliary diseases. Aliment. Pharmacol. Ther. 2002, 16:1037-1045.
96. Dutta U., Garg P.K., Kumar R., Tandon R.K. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am. J. Gastroenterol. 2000, 95:784-787.
97. Larsson S.C., Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br. J. Cancer 2007, 96:1457-1461.
98. Dhiman R.K., Chawla Y.K. Is there a link between oestrogen therapy and gallbladder disease?. Expert Opin. Drug Saf. 2006, 5:117-129.
99. Moerman C.J., Berns M.P., Bueno de Mesquita H.B., Runia S. Reproductive history and cancer of the biliary tract in women. Int. J. Cancer 1994, 57:146-153.
100. Tavani A., Negri E.L.V.C. Menstrual and reproductive factors and biliary tract cancers. Eur. J. Cancer Prev. 1996, 5:241-247.
101. Matsumoto Y., Fujii H., Aoyama H., Yamamoto M., Sugahara K., Suda K. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am. J. Surg. 1992, 163:239-245.
102. Ogura Y., Mizumoto R., Isaji S., Kusuda T., Matsuda S., Tabata M. Radical operations for carcinoma of the gallbladder: present status in Japan. World J. Surg. 1991, 15:337-343.
103. Suzuki A., Takahashi T. Histogenesis of the gallbladder carcinoma induced by methylcholanthrene beeswax pellets in hamsters. Jpn. J. Surg. 1983, 13:55-59.
104. Kowalewski K., Todd E.F. Carcinoma of the gallbladder induced in hamsters by insertion of cholesterol pellets and feeding dimethylnitrosamine. Proc. Soc. Exp. Biol. Med. 1971, 136:482-486.
105. Shukla V.K., Rastogi A.N., Adukia T.K., Raizada R.B., Reddy D.C., Singh S. Organochlorine pesticides in carcinoma of the gallbladder: a case-control study. Eur. J. Cancer Prev. 2001, 10:153-156.
106. Feigelson H.S., Ross R.K., Yu M.C., Coetzee G.A., Reichardt J.K., Henderson B.E. Genetic susceptibility to cancer from exogenous and endogenous exposures. J. Cell. Biochem. 1996, 25S:15-22.
107. Serra I., Yamamoto M., Calvo A., Cavada G., Baez S., Endoh K., Watanabe H., Tajima K. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int. J. Cancer 2002, 102:407-411.
108. Shukla V.K, Tiwari S.C., Roy S.K. Biliary bile acids in cholelithiasis and carcinoma of the gall bladder. Eur. J. Cancer Prev. 1993, 2:155-160.
109. Benbow E.W. Xanthogranulomatous cholecystitis. Br. J. Surg. 1990, 77:255-256.
110. Houlston R.S., Peto J. Genetic Predisposition to Cancer 1996, 208-226. Chapman and Hall, London. R.A. Eeles, B.A.J. Ponder, D.F. Easton, A. Horwich (Eds.).
111. Pandey M. Risk factors for gallbladder cancer: a reappraisal. Eur. J. Cancer Prev. 2003, 12:15-24.